A Study to Evaluate the Safety, Efficacy, and PPK of ABCD in Patients With IMD

Clinical trial NCT07239765 · COMPLETED

Trial details

NCT number: NCT07239765
Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Invasive Mold Disease

Start date: 2021-07-09
Primary completion: 2024-04-08
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.